...
首页> 外文期刊>Schizophrenia research >The use of polygenic risk scores to identify phenotypes associated with genetic risk of schizophrenia: Systematic review
【24h】

The use of polygenic risk scores to identify phenotypes associated with genetic risk of schizophrenia: Systematic review

机译:使用多基因风险评分来鉴定与精神分裂症的遗传风险相关的表型:系统评价

获取原文
获取原文并翻译 | 示例
           

摘要

Studying the phenotypic manifestations of increased genetic liability for schizophrenia can increase our understanding of this disorder. Specifically, information from alleles identified in genome-wide association studies can be collapsed into a polygenic risk score (PRS) to explore howgenetic risk ismanifestwithin different samples. In this systematic review, we provide a comprehensive assessment of studies examining associations between schizophrenia PRS (SZ-PRS) and several phenotypic measures. We searched EMBASE, Medline and PsycINFO (from August 2009-14th March 2016) plus references of included studies, following PRISMA guidelines. Study inclusion was based on predetermined criteria and data were extracted independently and in duplicate. Overall, SZ-PRS was associated with increased risk for psychiatric disorders such as depression and bipolar disorder, lower performance IQ and negative symptoms. SZ-PRS explained up to 6% of genetic variation in psychiatric phenotypes, compared to 0.7% in measures of cognition. Future gains fromusing the PRS approach may be greater if used for examining phenotypes that are more closely related to biological substrates, for scores based on genepathways, and where PRSs are used to stratify individuals for study of treatment response. As it was difficult to interpret findings across studies due to insufficient information provided by many studies, we propose a framework to guide robust reporting of PRS associations in the future. Crown Copyright (c) 2017 Published by Elsevier B. V. All rights reserved.
机译:研究精神分裂症遗传责任增加的表型表现可以增加我们对这种疾病的理解。具体而言,可以将来自基因组关联研究中鉴定的等位基因的信息折叠成多基因风险评分(PRS),以探索如何为不同样品的诺曼原因。在该系统审查中,我们对研究审查精神分裂症(SZ-PR)和几种表型措施的研究提供了全面评估。我们搜索了Embase,Medline和Psycinfo(从2016年8月4日起)加上普遍研究的参考,遵循PRISMA准则。研究包容基于预定标准,并且独立提取数据并重复提取数据。总体而言,SZ-PRS与精神疾病的风险增加有关,例如抑郁和双相情感障碍,较低的性能智商和阴性症状。与&&的认知措施相比,Sz-Prs解释了精神表型遗传变异的6%。如果用于检查与生物基质更密切相关的表型,则从基于生物底物相关的表型来进行未来的收益可能更大,并且使用PRSS分层用于研究治疗反应的个体。由于许多研究提供的信息不足,因此难以解释跨研究的发现,我们提出了一个框架,以指导未来的PRS协会的强劲报告。皇冠版权(c)2017由Elsevier B. V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号